Author Question: A nurse in the intensive care unit (ICU) receives report from the nurse in the emergency department ... (Read 55 times)

torybrooks

  • Hero Member
  • *****
  • Posts: 500
A nurse in the intensive care unit (ICU) receives report from the nurse in the emergency department (ED) about a new patient being admitted with a spinal cord injury received while diving into a lake.
 
  The ED nurse reports that his blood pressure is 85/54, heart rate is 53 beats per minute, and his skin is warm and dry. What does the ICU nurse recognize that the patient is probably experiencing?
  A) Anaphylactic shock
  B) Neurogenic shock
  C) Septic shock
  D) Hypovolemic shock

Question 2

A patient is receiving dopamine, a vasoactive drug used for shock, to increase stroke volume. What should the nurse be aware of when monitoring a vasoactive drug?
 
  A) The drug should be discontinued immediately after blood pressure increases.
  B) The drug dose should be weaned down prior to discontinuing.
  C) The drug may cause respiratory alkalosis.
  D) The drug reduces oxygen demands of the heart.



Sweetkitty24130

  • Sr. Member
  • ****
  • Posts: 291
Answer to Question 1

B

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

Normal urine is sterile. It contains fluids, salts, and waste products. It is free of bacteria, viruses, and fungi.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library